Back to results
UnknownPhase 4

Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety

NCT05915949

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Contact

Minji Sohn, PhD

82-031-787-704165423@snuhb.org
View on ClinicalTrials.gov
Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety — TrialFind